Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction

• Main Authors: Jinhao Zeng (Author), Xiao Ma (Author), Ziyi Zhao (Author), Yu Chen (Author), Jundong Wang (Author), Yanwei Hao (Author), Junrong Yu (Author), Zhongzhen Zeng (Author), Nianzhi Chen (Author), Maoyuan Zhao (Author), Jianyuan Tang (Author), Daoyin Gong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Seeking novel and effective therapies for gastric precancerous lesions (GPL) is crucial to reducing the incidence of gastric cancer. Ginsenoside Rb1 (GRb1) is a major ginsenoside in ginseng and has been proved to possess multiple bioactivities. However, whether GRb1 could protect against...